BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29286443)

  • 1. Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions.
    Slamecka J; Laurini J; Shirley T; Hoerstrup SP; Weber B; Owen L; McClellan S
    J Vis Exp; 2017 Nov; (129):. PubMed ID: 29286443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions.
    Slamecka J; Salimova L; McClellan S; van Kelle M; Kehl D; Laurini J; Cinelli P; Owen L; Hoerstrup SP; Weber B
    Cell Cycle; 2016; 15(2):234-49. PubMed ID: 26654216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
    Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of human amniotic fluid mesenchymal stem cells as the feeder layer to establish human embryonic stem cell lines.
    Soong YK; Huang SY; Yeh CH; Wang TH; Chang KH; Cheng PJ; Shaw SW
    J Tissue Eng Regen Med; 2015 Dec; 9(12):E302-7. PubMed ID: 23460275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of spontaneously contracting cardiomyocytes from non-virally reprogrammed human amniotic fluid stem cells.
    Velasquez-Mao AJ; Tsao CJM; Monroe MN; Legras X; Bissig-Choisat B; Bissig KD; Ruano R; Jacot JG
    PLoS One; 2017; 12(5):e0177824. PubMed ID: 28545044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.
    Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC
    Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amniotic fluid cells are more efficiently reprogrammed to pluripotency than adult cells.
    Galende E; Karakikes I; Edelmann L; Desnick RJ; Kerenyi T; Khoueiry G; Lafferty J; McGinn JT; Brodman M; Fuster V; Hajjar RJ; Polgar K
    Cell Reprogram; 2010 Apr; 12(2):117-25. PubMed ID: 20677926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced pluripotent stem cells derived from human amnion in chemically defined conditions.
    Slamecka J; McClellan S; Wilk A; Laurini J; Manci E; Hoerstrup SP; Weber B; Owen L
    Cell Cycle; 2018; 17(3):330-347. PubMed ID: 29143560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced pluripotent stem (iPS) cells from human fetal stem cells.
    Guillot PV
    Best Pract Res Clin Obstet Gynaecol; 2016 Feb; 31():112-20. PubMed ID: 26427551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells.
    Li C; Zhou J; Shi G; Ma Y; Yang Y; Gu J; Yu H; Jin S; Wei Z; Chen F; Jin Y
    Hum Mol Genet; 2009 Nov; 18(22):4340-9. PubMed ID: 19679563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A highly optimized protocol for reprogramming cancer cells to pluripotency using nonviral plasmid vectors.
    Zhao H; Davies TJ; Ning J; Chang Y; Sachamitr P; Sattler S; Fairchild PJ; Huang FP
    Cell Reprogram; 2015 Feb; 17(1):7-18. PubMed ID: 25549177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation and periodontal differentiation of human gingival fibroblasts-derived integration-free induced pluripotent stem cells.
    Yin X; Li Y; Li J; Li P; Liu Y; Wen J; Luan Q
    Biochem Biophys Res Commun; 2016 May; 473(3):726-32. PubMed ID: 26456649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Establishment of induced pluripotent stem cell lines from human amniotic fluid cells with 1q21.1 microdeletion].
    Gong Y; Li Y; Song Y; Sun X; Song B; Sun W; Chen X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Apr; 32(2):175-9. PubMed ID: 25863080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced pluripotent stem (iPS) cells from human fetal stem cells (hFSCs).
    Spinelli V; Guillot PV; De Coppi P
    Organogenesis; 2013; 9(2):101-10. PubMed ID: 23823661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Cardiomyocytes Prior to Birth by Integration-Free Reprogramming of Amniotic Fluid Cells.
    Jiang G; Herron TJ; Di Bernardo J; Walker KA; O'Shea KS; Kunisaki SM
    Stem Cells Transl Med; 2016 Dec; 5(12):1595-1606. PubMed ID: 27465073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of alkaline phosphatase-positive induced pluripotent stem cells from human amniotic fluid-derived cells by feeder-free system.
    Lu HE; Tsai MS; Yang YC; Yuan CC; Wang TH; Lin XZ; Tseng CP; Hwang SM
    Exp Cell Res; 2011 Aug; 317(13):1895-903. PubMed ID: 21640101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced pluripotent stem cell lines derived from human gingival fibroblasts and periodontal ligament fibroblasts.
    Wada N; Wang B; Lin NH; Laslett AL; Gronthos S; Bartold PM
    J Periodontal Res; 2011 Aug; 46(4):438-47. PubMed ID: 21443752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct Reprogramming of Human Amniotic Fluid Stem Cells by OCT4 and Application in Repairing of Cerebral Ischemia Damage.
    Qin M; Chen R; Li H; Liang H; Xue Q; Li F; Chen Y; Zhang X
    Int J Biol Sci; 2016; 12(5):558-68. PubMed ID: 27019637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A facile method to establish human induced pluripotent stem cells from adult blood cells under feeder-free and xeno-free culture conditions: a clinically compliant approach.
    Chou BK; Gu H; Gao Y; Dowey SN; Wang Y; Shi J; Li Y; Ye Z; Cheng T; Cheng L
    Stem Cells Transl Med; 2015 Apr; 4(4):320-32. PubMed ID: 25742692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High efficiency of reprogramming CD34⁺ cells derived from human amniotic fluid into induced pluripotent stem cells with Oct4.
    Liu T; Zou G; Gao Y; Zhao X; Wang H; Huang Q; Jiang L; Guo L; Cheng W
    Stem Cells Dev; 2012 Aug; 21(12):2322-32. PubMed ID: 22264161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.